Evolent Health Stock Analysis

EVH Stock  USD 9.58  0.38  3.82%   
Evolent Health is undervalued with Real Value of 12.84 and Target Price of 23.75. The main objective of Evolent Health stock analysis is to determine its intrinsic value, which is an estimate of what Evolent Health is worth, separate from its market price. There are two main types of Evolent Health's stock analysis: fundamental analysis and technical analysis.
The Evolent Health stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Evolent Health's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolent Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.

Evolent Stock Analysis Notes

About 97.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.16. Some equities with similar Price to Book (P/B) outperform the market in the long run. Evolent Health recorded a loss per share of 0.81. The entity had not issued any dividends in recent years. Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. The company was founded in 2011 and is headquartered in Arlington, Virginia. Evolent Health operates under Health Information Services classification in the United States and is traded on New York Stock Exchange. It employs 3500 people. To learn more about Evolent Health call Dan McCarthy at 571 389 6000 or check out https://www.evolent.com.

Evolent Health Investment Alerts

Evolent Health generated a negative expected return over the last 90 days
Evolent Health has high historical volatility and very poor performance
The company reported the last year's revenue of 2.55 B. Reported Net Loss for the year was (61.62 M) with profit before taxes, overhead, and interest of 367.35 M.
Over 97.0% of the company shares are held by institutions such as insurance companies
Latest headline from finance.yahoo.com: 1 Healthcare Stock on Our Watchlist and 2 to Turn Down

Evolent Health Upcoming and Recent Events

Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Evolent Health previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
28th of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Evolent Largest EPS Surprises

Earnings surprises can significantly impact Evolent Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2020-11-05
2020-09-30-0.04-0.030.0125 
2018-08-07
2018-06-30-0.04-0.030.0125 
2021-08-04
2021-06-30-0.04-0.020.0250 
View All Earnings Estimates

Evolent Health Environmental, Social, and Governance (ESG) Scores

Evolent Health's ESG score is a quantitative measure that evaluates Evolent Health's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Evolent Health's operations that may have significant financial implications and affect Evolent Health's stock price as well as guide investors towards more socially responsible investments.

Evolent Stock Institutional Investors

Shares
Jpmorgan Chase & Co2024-12-31
3.2 M
State Street Corp2024-12-31
M
Dimensional Fund Advisors, Inc.2024-12-31
2.9 M
Geode Capital Management, Llc2024-12-31
2.5 M
Boston Partners Global Investors, Inc2024-12-31
2.4 M
Rock Springs Capital Management Lp2024-12-31
2.1 M
Ubs Group Ag2024-12-31
1.8 M
Blair William & Co2024-12-31
1.7 M
Bank Of New York Mellon Corp2024-12-31
1.4 M
Vanguard Group Inc2024-12-31
11.2 M
Wellington Management Company Llp2024-12-31
10.4 M
Note, although Evolent Health's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Evolent Market Capitalization

The company currently falls under 'Mid-Cap' category with a total capitalization of 1.16 B.

Evolent Profitablity

The company has Net Profit Margin of (0.02) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.08)(0.09)
Return On Capital Employed(0.02)(0.02)
Return On Assets(0.02)(0.03)
Return On Equity(0.06)(0.06)

Management Efficiency

The current Return On Tangible Assets is estimated to decrease to -0.09. The current Return On Capital Employed is estimated to decrease to -0.02. As of now, Evolent Health's Debt To Assets are increasing as compared to previous years. The Evolent Health's current Fixed Asset Turnover is estimated to increase to 33.83, while Total Assets are projected to decrease to under 1.4 B. Evolent Health's management efficiency ratios could be used to measure how well Evolent Health manages its routine affairs as well as how well it operates its assets and liabilities.
Last ReportedProjected for Next Year
Book Value Per Share 8.73  8.29 
Tangible Book Value Per Share(7.12)(6.76)
Enterprise Value Over EBITDA 17.60  18.48 
Price Book Value Ratio 1.29  1.35 
Enterprise Value Multiple 17.60  18.48 
Price Fair Value 1.29  1.35 
Enterprise Value749.4 M742.8 M
The leadership approach at Evolent Health's fosters a culture of excellence and accountability. Our analysis examines how this culture influences financial outcomes and stock valuation.
Operating Margin
(0.0009)
Profit Margin
(0.02)
Beta
1.494
Return On Assets
0.0006
Return On Equity
(0.05)

Technical Drivers

As of the 22nd of March, Evolent Health shows the Mean Deviation of 2.45, standard deviation of 3.4, and Variance of 11.58. Evolent Health technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Evolent Health Price Movement Analysis

Execute Study
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Evolent Health middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Evolent Health. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Evolent Health Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Evolent Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Evolent Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Evolent Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Evolent Health Outstanding Bonds

Evolent Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Evolent Health uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Evolent bonds can be classified according to their maturity, which is the date when Evolent Health has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Evolent Health Predictive Daily Indicators

Evolent Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Evolent Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Evolent Health Corporate Filings

F4
10th of March 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
5th of March 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
4th of March 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
10K
21st of February 2025
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
ViewVerify
8K
20th of February 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F3
14th of February 2025
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
10th of February 2025
Other Reports
ViewVerify
8K
4th of February 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify

Evolent Health Forecast Models

Evolent Health's time-series forecasting models are one of many Evolent Health's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Evolent Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Evolent Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Evolent Health prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Evolent shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Evolent Health. By using and applying Evolent Stock analysis, traders can create a robust methodology for identifying Evolent entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(0.02)(0.03)
Operating Profit Margin(0.02)(0.02)
Net Loss(0.02)(0.02)
Gross Profit Margin 0.14  0.18 

Current Evolent Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Evolent analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Evolent analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
23.75Strong Buy16Odds
Evolent Health current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Evolent analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Evolent stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Evolent Health, talking to its executives and customers, or listening to Evolent conference calls.
Evolent Analyst Advice Details

Evolent Stock Analysis Indicators

Evolent Health stock analysis indicators help investors evaluate how Evolent Health stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Evolent Health shares will generate the highest return on investment. By understating and applying Evolent Health stock analysis, traders can identify Evolent Health position entry and exit signals to maximize returns.
Begin Period Cash Flow223.5 M
Long Term Debt490.5 M
Common Stock Shares Outstanding114.7 M
Total Stockholder EquityB
Tax Provision-1.4 M
Property Plant And Equipment Net79.3 M
Cash And Short Term Investments163.5 M
Cash104.2 M
Accounts Payable96 M
Net Debt119 M
50 Day M A10.0792
Total Current Liabilities715.5 M
Other Operating Expenses2.6 B
Non Current Assets Total1.9 B
Forward Price Earnings17.3611
Non Currrent Assets Other31.9 M
Stock Based Compensation39.7 M

Complementary Tools for Evolent Stock analysis

When running Evolent Health's price analysis, check to measure Evolent Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolent Health is operating at the current time. Most of Evolent Health's value examination focuses on studying past and present price action to predict the probability of Evolent Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolent Health's price. Additionally, you may evaluate how the addition of Evolent Health to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
CEOs Directory
Screen CEOs from public companies around the world
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets